Despite their success, immune checkpoint blockers (ICB) benefit only a subset of patients and pose potential risk of serious immune-related adverse events, underscoring the critical need for new strat
Many cancers recruit monocytes/macrophages and polarize them into tumor-associated macrophages (TAMs). TAMs promote tumor growth and metastasis and inhibit cytotoxic T cells, preventing immune control
Background: Immunotherapy utilizing T cells genetically modified to express chimeric antigen receptors (CARs) is rapidly emerging as a promising novel treatment for hematological and nonhematological
Diverse combination therapies are being investigated to overcome the limitations of immune checkpoint inhibitors. However, determining the optimal combination therapy remains a challenge. Herein, we d
Parameter Estimates for Multinomial Logistic Regression. Parameter Estimates for Cox Proportional Hazards Model of Overall Survival. Parameter Estimates for Cox Proportional Hazards Model of Progre
